Analyzing SARS-CoV-2 Drugs Remdesivir and GS-441524

Sponsored Content

A fast separation of remdesivir and its active metabolite GS-441524 for the treatment of COVID-19 is obtained in only 3 minutes using a YMC-Triart C18 UHPLC column.